There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 mg | ||
| 2 mg | ||
| 5 mg |
| Product Overview | Recombinant Human LGALS3BP protein (NP_005558.1) is produced in Glycoengineered Pichia pastoris. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications. |
| Source | Glycoengineered Pichia pastoris |
| Species | Human |
| Tag | His-Tag, FC-Tag or other Tags as required. |
| Purity | >90% |
| Endotoxin Level | Regular batch |
| Conjugation | None |
| Target | LGALS3BP |
| Full Name | Galectin-3-binding protein |
| Gene ID | 3959 |
| Uniprot ID | Q08380 |
| Accession Number | NP_005558.1 |
| Background | The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS3BP has been found elevated in the serum of patients with cancer and in those infected by the human immunodeficiency virus (HIV). It appears to be implicated in immune response associated with natural killer (NK) and lymphokine-activated killer (LAK) cell cytotoxicity. |
| Alternate Names | 90K; M2BP; gp90; CyCAP; BTBD17B; MAC-2-BP; TANGO10B |